Titus B. Ball - Sep 2, 2025 Form 4 Insider Report for BeOne Medicines Ltd. (ONC)

Role
Principal Accounting Officer
Signature
/s/ Qing Nian, as Attorney-in-Fact
Stock symbol
ONC
Transactions as of
Sep 2, 2025
Transactions value $
-$39,865
Form type
4
Date filed
9/4/2025, 05:29 PM
Previous filing
Jun 12, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ball Titus B. Principal Accounting Officer C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, SWITZERLAND /s/ Qing Nian, as Attorney-in-Fact 2025-09-04 0001675628

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONC American Depositary Shares Sale -$39.9K -122 -100% $326.76 0 Sep 2, 2025 Direct F1, F2
holding ONC Ordinary Shares 72.4K Sep 2, 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share represents 13 Ordinary Shares.
F2 The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of August 31, 2023, subject to continued service.